I'm 22 Years Old. The Past 2 Years Were The BEST & Most Successful Years Of My Life. So Much More Success & Blessings Ahead For Me, & My Students. I Got Millionaire Students In The Making & I Want More! 💎Who's Ready To Be My Next Forex Millionaire Student?! Copy all my trades with the signals or learn all my strategies in the course.. DM to get started! 📈💎💰
Join The Millionaire Forex Team 📈Most Of My Clients / Students Average 400$£400+ A Week from my signals! 💰💎 -
Join My Course Today & Learn The Way Banks Trade, Learn Powerful Strategies & Much More!💰
What Do i Offer? I offer Forex / Binary signals & a forex course. With my signals you can copy my live trades and profit with me! I also offer a course were you can learn all my profitable strategies, and it includes free signals for 1 year!
Learn Forex From me, The Millionaire Forex Team! My Strategy & Signals Can Help You Make Serious Money, 95% Of My Customers Are Very Happy With Their Results. Some Of My Students / Clients Earn Around £400/400$+ Daily. 💎
Who Am I? I Have Been Trading For 6+ Years, Traded Alongside Bankers, I Teach All My Profitable Strategies In My Forex Course & Let You Copy My Profitable Trades With My Forex Signals 🚀
To Get Started With My Signals Or Course.. DM me fast, #ellsworthfx is your instructor
This Years Goal Is To Make 5+ Millionaires From My Forex Course, Which Includes The " Millionaire Challenge " ✅ ---------------------------------
Interesting chart setup on . Has held support multiple times. Definitely one to monitor for a breakout to either side. Let me know your thoughts! .
For FREE group chat access for daily walk throughs on market opportunities such as this one- click the link in my bio!
Minnesota is home to biopharma's such as Upsher-Smith Laboratories and ANI Pharmaceuticals, but Takeda's plant in Brooklyn Park will be the largest biopharma site in the state, with more square footage than a SuperTarget.
The Brooklyn Park plant is working on its "process performance qualification" batches for Entyvio, and data from those test batches will be used to pass the U.S. FDA's standard drug-plant inspection process. Takeda acquired the 14-year-old plant in Brooklyn Park from Baxalta in December 2015, and has been working to bring it online since then. By roughly this time next year, Takeda hopes to be making real doses of the active ingredient for Entyvio.
🌤 Growing up we were always told you keep our head out of the clouds... no thanks I like it up here‼️ don't always listen to people who think they know what's best for you, only you know what's best for you, as long as your 100% honest with yourself how your PROGRESSING. ••••••••••••••••••••••••••••••••••••••••
BE GREAT, you’re worth it💪
➡️➡️ New Era Investments ⬅️⬅️
🙌 Much blessings and success to you all, then pass it on🤝💯
A New York lawyer was sentenced to 18 months prison on Friday for helping Martin Shkreli, currently serving a seven year prison sentence after being convicted of related charges, defraud a drug company that Shkreli had founded.
Evan Greebel, who was outside counsel to Shkreli's former company Retrophin, was sentenced by U.S. District Judge Kiyo Matsumoto in Brooklyn.
His lawyers had asked that he be given no jail time, while prosecutors had asked for five years. The judge also ordered Greebel to pay about $10.4 million in restitution to Retrophin.
Ziylo and Novo Nordisk have announced that Novo Nordisk has acquired all of the shares of Ziylo.
The acquisition gives Novo Nordisk full rights to Ziylo's glucose binding molecule platform to develop glucose responsive insulins. Novo Nordisk acquires all shares in Ziylo for an upfront payment and earn-outs with contingent milestone payments.
Total payments under the agreement could ultimately exceed $800 million upon the achievement of certain development, regulatory and sales milestones by Novo Nordisk.
Prior to closing of the acquisition, certain research activities have been spun out of Ziylo to a new company, Carbometrics
Facebook wants to revolutionise MRI (magnetic resonance imaging) scans.
The social networking giant announced on Monday a new research project that aims to use artificial intelligence (AI) to make MRI scans up to ten times faster, and has been granted access to a trove of around 3 million anonymised MRI images from 10,000 clinical cases.
In an announcement blog post, Facebook said the data it has accessed has had patient names removed, as well as "all other protected health information," and the project is compliant with HIPAA privacy regulations.
The project is a collaboration between Facebook's FAIR AI research lab and NYU School of Medicine's Department of Radiology.